
AI‑powered point‑of‑care diagnostics for faster, accurate pathology

Book a personalized demo with our team.
Aindra leverages AI, deep learning, optics, and mechatronics to transform clinical pathology workflows by automating slide analysis and reducing turnaround times. Its flagship suite, CervAstra, integrates automated staining, high‑resolution imaging, and AI‑driven slide interpretation to detect abnormalities with precision. Targeted at labs, hospitals, and primary health centers, this platform helps extend quality diagnostics to underserved populations. The company emphasizes affordability and accessibility in its mission to democratize healthcare.
Healthcare Providers, Diagnostic Labs, Hospitals, Telemedicine Networks, Public Health Programs
Bengaluru, India
11-50 employees